Artificial Intelligence | Machine Learning | Natural Language Processing Verge Genomics | Building Enduring Biotechnology Company


Enterprise, Bioinformatics, Genomics, Drug Discovery, Neuroscience San Francisco, California, United States

Verge Genomics

Artificial Intelligence | Machine Learning | Natural Language Processing


Verge Genomics | Building Enduring Biotechnology Company

Verge Genomics

Bioinformatics, Genomics, Drug Discovery, Neuroscience


San Francisco, California, United States

Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate the development of life-saving treatments for neurodegenerative diseases. Our platform uses patient genomes, gene expression, and epigenomics to identify new therapeutic gene targets, predict effective drugs, and stratify patient subpopulations for increased clinical success. Verge's approach offers a breakthrough opportunity to identify drugs that dramatically improve patient outcomes and fundamentally lower the cost curve of pharmaceutical development. Verge has pioneered the industry's most advanced all-in-human, artificial intelligence-powered drug discovery platform to unlock new drugs at scale for the biggest medical challenges of our time.

Our mission is to develop better drugs and faster-using technology. Verge was born from the convergence of multiple technological forces, including human genomics, machine learning, biological engineering, and translational medicine, that are enabling us to decipher biology. Instead of using animal or cell models, we have built one of the world's largest proprietary multi-omics databases directly from human tissue. We use machine learning to map the complex causes of disease and develop those insights into proprietary drug candidates on our internal biology and chemistry platforms. We are developing drugs to treat the biggest medical challenges of our generation. Our first drug is anticipated to enter the clinic this year for ALS and was discovered entirely from our platform. We are working on a dozen breakthrough opportunities for Parkinson's Disease, Frontotemporal Dementia, and other devastating diseases with no effective treatments to date.

 

B2B

51 to 100

Series B

$134.1M

Scaling Up

2015

 
 

Biotechnology

Improve Patient Outcomes
Reduce Cost of Drug Development

Increase Productivity
Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Natural Language Processing


Drug Discovery

Drug Discovery


Text

Text

Structured

Structured

 

   Software


Python

Python

C/C++

C/C++

Node.js

Node.js

AWS Redshift

AWS Redshift

PostgreSQL

PostgreSQL

Docker

Docker

Tensorflow

Tensorflow


Machine Learning Algorithm

Machine Learning Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

May 2022

  • Verge Genomics Named to Forbes top 50 AI List
 
 

View All

Head of People

Remote , Remote

(Senior) Research Associate - Disease Modeling Core

San Francisco, California

(Principal/Senior Scientist), Team Lead of the Disease Modeling Core

San Francisco, California

 

AI/ML Professionals

Want to work at Verge Genomics?

We can introduce you to the right person at Verge Genomics

Talk to our Talent Team

 

4

1

$32M

Company was founded 2015 and it took almost 7 years (Jul 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

07/27/2022

Series A

$32M

DFJ Growth, Agent Capital, ALS Investment Fund, OS Fund

Date : 07/27/2022

Round: Series A

$ Raised: $32M

Investors: DFJ Growth, Agent Capital, ALS Investment Fund, OS Fund

 

Investors

Interested in researching Verge Genomics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Verge Genomics

Request a Demo - Deal Souring Platform

 
Alice Zhang

Alice Zhang
Chief Executive Officer and Co-founder

Jason Chen

Jason Chen
Co-founder

Jane Rhodes

Jane Rhodes
Chief Business Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Verge Genomics